國家衛生研究院 NHRI:Item 3990099045/2278
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 909386      Online Users : 721
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/2278


    Title: Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study
    Authors: King, JK;Yeh, SH;Lin, MW;Liu, CJ;Lai, MY;Kao, JH;Chen, DS;Chen, PJ
    Contributors: Division of Molecular and Genomic Medicine
    Abstract: Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis B. However, sustained remission rates remain relatively low, and the search for factors important for response to therapy continues. Our study aimed to identify the host single nucleotide polymorphisms (SNPs) that predict IFN response in hepatitis B patients. We selected genes in the IFN pathway involved in antiviral and signaling activities and sequenced 22 SNPs for each of our 82 patients. Our results identified 2 SNPs in the antiviral pathway that may influence IFN response. One SNP in the regulatory region of the eIF-2alpha gene revealed A/G alleles. The rate of A/G heterozygotes is 22% in nonresponders (NR) and 2% in sustained responders (R), with an odds ratio (OR) of 12.82 (95% CI: 1.52-107.85, P = .009). After adjustment for age, sex, and HBV DNA level, the OR reaches 14.94 (95% Cl: 1.45-153-71, P = .023). This marker revealed greater significance than HBV DNA levels (OR. 5, 95% CI: 1.01-2.43, P = .033) as a marker for IFN response, suggesting its potential advantage over conventional predictors. In addition, borderline significance for the SNP in MxA gene promoter at nt - 88 revealed G/T alleles, with the G/T heterozygote rate being 19% in nonresponders and 43% in sustained R (P = .061), concurring with a previous study involving hepatitis C patients. In conclusion, this pilot identified SNPs as potential markers that could predict hepatitis B patient response. These observations may help guide future large-scale studies in examining host SNPs for their clinical utility in predicting IFN response.
    Keywords: Gastroenterology & Hepatology
    Date: 2002-12
    Relation: Hepatology. 2002 Dec;36(6):1416-1424.
    Link to: http://dx.doi.org/10.1002/hep.1840360618
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0270-9139&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000179536300015
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84983726619
    Appears in Collections:[Shiou-Hwei Yeh(2001-2005)] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    000179536300015.pdf117KbAdobe PDF866View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback